Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

RSV causes 160,000 hospitalizations every year in the EU, according to new study

Researchers estimate hospitalizations associated with respiratory syncytial virus infection in the European Union.

20 Mar 2023

How does SARS-CoV-2 interact with other pathogens?

In a recent study published in the PLOS Pathogens journal, researchers examine the present body of information regarding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interactions.

13 Mar 2023

Novel predictors of severe respiratory syncytial virus infections among infants below the age of one

Researchers examined predictors for hospitalization due to respiratory syncytial virus (RSV) infections to develop a clinical model for guiding immunization and prophylactic treatment of one-year-old infants against RSV infections.

3 Mar 2023

A review of respiratory viruses monitored in wastewater samples

Researchers review previous studies discussing the content or respiratory viruses in wastewater samples.

28 Feb 2023

Innovative methodology to detect viral RNA

Experts from the University of Barcelona, the Institute for Advanced Chemistry of Catalonia, the Institute of Microelectronics of Barcelona and the Aragon Nanoscience and Materials Institute of Aragon —a joint institute of the CSIC and the University of Zaragoza— have developed a new method to detect RNA viruses based on the triplex-forming probe technology.

27 Feb 2023

UCI-led study uncovers how APOBEC3B protein could protect cells against RNA viruses

A new University of California, Irvine-led study uncovers how a protein, APOBEC3B, could protect cells against many different types of RNA viruses like respiratory syncytial virus (RSV), SARS-CoV2, influenza virus, poliovirus and measles, helping to prevent disease.

22 Feb 2023

Study finds RSV responsible for most infant hospitalizations in the European Union

In a recent study posted to the medRxiv* preprint server, researchers used statistical modeling to estimate hospitalizations due to respiratory syncytial virus (RSV) infections in children under five years of age in 28 nations of the European Union (EU) and Norway.

15 Feb 2023

Study estimates the associations of global and regional antibiotic use with COVID-19 cases and vaccinations during 2020–2022

Researchers evaluated the association between COVID-19 cases and vaccinations with antibiotic use worldwide during the SARS-CoV-2 pandemic between 2020 and 2022.

9 Feb 2023

The impact of common viral infections on blood-brain barrier function and insulin sensitivity

A new study discusses the impact of several human viruses on blood-brain barrier function and insulin sensitivity.

31 Jan 2023

Researchers explore respiratory syncytial virus infection before and during the COVID-19 pandemic

Researchers assessed the occurrence of respiratory syncytial virus (RSV) infection prior tobefore and at the time of the coronavirus disease 2019 (COVID-19) pandemic.

27 Jan 2023

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

Researchers recently assessed the clinical impact and epidemiology of viral co-detections in children in the United States of America (USA) during the coronavirus disease 2019 (COVID-19) pandemic.

23 Jan 2023

Study reviews mechanistic data on new methods of allergy prevention and treatment

In a recent article published in Science Translational Medicine, researchers reviewed the cause and the underlying pathophysiology of allergic diseases.

23 Jan 2023

Threshold control method could aid in future non-pharmaceutical intervention relaxation policy making

Governments around the world used a variety of techniques known as nonpharmaceutical interventions, or NPIs, to control the spread of COVID-19.

18 Jan 2023

Novel peptide suppresses the damaging lung inflammation seen in ARDS

A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS.

17 Jan 2023

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

In a recent review, the former director of the National Institute of Allergy and Infectious Diseases and former chief medical advisor to the president of the United States (U.S.), Dr. Fauci, and his team review the roadblocks to developing effective vaccines against viruses that infect the human respiratory mucosa and discuss strategies for next-generation vaccine development against mucosal respiratory viruses

13 Jan 2023

The 2022 U.S. RSV surge consisted of a variety of pre-existing viruses

In a recent study posted to the medRxiv* preprint server, researchers investigated whether the upsurge in respiratory syncytial virus (RSV) infections during the autumn season of 2022 occurred due to the emergence of a novel, highly transmissible RSV strain or whether multiple pre-existing RSV strains were responsible for the increase in RSV case counts during the period.

12 Jan 2023

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

RSV causes 160,000 hospitalizations every year in the EU, according to new study

How does SARS-CoV-2 interact with other pathogens?

Novel predictors of severe respiratory syncytial virus infections among infants below the age of one

A review of respiratory viruses monitored in wastewater samples

Innovative methodology to detect viral RNA

UCI-led study uncovers how APOBEC3B protein could protect cells against RNA viruses

Study finds RSV responsible for most infant hospitalizations in the European Union

Study estimates the associations of global and regional antibiotic use with COVID-19 cases and vaccinations during 2020–2022

The impact of common viral infections on blood-brain barrier function and insulin sensitivity

Researchers explore respiratory syncytial virus infection before and during the COVID-19 pandemic

Exploring the clinical impact of co-detections of other respiratory viruses in US children hospitalized for COVID-19

Study reviews mechanistic data on new methods of allergy prevention and treatment

Threshold control method could aid in future non-pharmaceutical intervention relaxation policy making

Novel peptide suppresses the damaging lung inflammation seen in ARDS

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

The 2022 U.S. RSV surge consisted of a variety of pre-existing viruses

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

What was the prevalence of respiratory syncytial virus between August and December 2022?

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Respiratory Syncytial Virus (RSV) News and Research

Latest Respiratory Syncytial Virus (RSV) News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in